<DOC>
	<DOC>NCT02054754</DOC>
	<brief_summary>The purpose of this study is to test the safety and observe the pharmacokinetics (distribution and elimination of the drug) of the compound dexanabinol (ETS2101) in healthy male subjects following a single oral dose.</brief_summary>
	<brief_title>Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>HU 211</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>Healthy males aged 18 to 45 years Body mass index 18.0 to 32.0 kg/m2, or if outside the range, considered not clinically significant by the investigator Participation in a clinical research study within the previous 3 months Current smokers and those who have smoked within the last 12 months History of any drug or alcohol abuse in the past 2 years</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Dexanabinol</keyword>
	<keyword>Oral</keyword>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>